Table of Contents

2019-2024 Global Daratumumab Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Daratumumab Consumption 2014-2024
  • 2.1.2 Daratumumab Consumption CAGR by Region
• 2.2 Daratumumab Segment by Type
  • 2.2.1 100mg Injection
  • 2.2.2 400mg Injection
• 2.3 Daratumumab Consumption by Type
  • 2.3.1 Global Daratumumab Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Daratumumab Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Daratumumab Sale Price by Type (2014-2019)
• 2.4 Daratumumab Segment by Application
  • 2.4.1 Multiple Myeloma
  • 2.4.2 Diffuse Large B Cell Lymphoma
  • 2.4.3 Follicular Lymphoma
  • 2.4.4 Mantle Cell Lymphoma
  • 2.4.5 Other
• 2.5 Daratumumab Consumption by Application
  • 2.5.1 Global Daratumumab Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Daratumumab Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Daratumumab Sale Price by Application (2014-2019)

3 Global Daratumumab by Manufacturers

• 3.1 Global Daratumumab Sales Market Share by Manufacturers
  • 3.1.1 Global Daratumumab Sales by Manufacturers (2017-2019)
  • 3.1.2 Global Daratumumab Sales Market Share by Manufacturers (2017-2019)
• 3.2 Global Daratumumab Revenue Market Share by Manufacturers
  • 3.2.1 Global Daratumumab Revenue by Manufacturers (2017-2019)
  • 3.2.2 Global Daratumumab Revenue Market Share by Manufacturers (2017-2019)
• 3.3 Global Daratumumab Sale Price by Manufacturers
• 3.4 Global Daratumumab Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
  • 3.4.1 Global Daratumumab Manufacturing Base Distribution and Sales Area by Manufacturers
  • 3.4.2 Players Daratumumab Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Daratumumab by Regions

• 4.1 Daratumumab by Regions
  • 4.1.1 Global Daratumumab Consumption by Regions
  • 4.1.2 Global Daratumumab Value by Regions
• 4.2 Americas Daratumumab Consumption Growth
• 4.3 APAC Daratumumab Consumption Growth
• 4.4 Europe Daratumumab Consumption Growth
• 4.5 Middle East & Africa Daratumumab Consumption Growth

5 Americas

• 5.1 Americas Daratumumab Consumption by Countries
  • 5.1.1 Americas Daratumumab Consumption by Countries (2014-2019)
  • 5.1.2 Americas Daratumumab Value by Countries (2014-2019)
• 5.2 Americas Daratumumab Consumption by Type
• 5.3 Americas Daratumumab Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Daratumumab Consumption by Countries
  • 6.1.1 APAC Daratumumab Consumption by Countries (2014-2019)
  • 6.1.2 APAC Daratumumab Value by Countries (2014-2019)
• 6.2 APAC Daratumumab Consumption by Type
• 6.3 APAC Daratumumab Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Daratumumab by Countries
  • 7.1.1 Europe Daratumumab Consumption by Countries (2014-2019)
  • 7.1.2 Europe Daratumumab Value by Countries (2014-2019)
• 7.2 Europe Daratumumab Consumption by Type
• 7.3 Europe Daratumumab Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Daratumumab by Countries
  • 8.1.1 Middle East & Africa Daratumumab Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Daratumumab Value by Countries (2014-2019)
• 8.2 Middle East & Africa Daratumumab Consumption by Type
• 8.3 Middle East & Africa Daratumumab Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Daratumumab Distributors
• 10.3 Daratumumab Customer

11 Global Daratumumab Market Forecast

• 11.1 Global Daratumumab Consumption Forecast (2019-2024)
• 11.2 Global Daratumumab Forecast by Regions
  • 11.2.1 Global Daratumumab Forecast by Regions (2019-2024)
  • 11.2.2 Global Daratumumab Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Daratumumab Forecast by Type
• 11.8 Global Daratumumab Forecast by Application

12 Key Players Analysis

• 12.1 Johnson＆Johnson
  • 12.1.1 Company Details
  • 12.1.2 Daratumumab Product Offered
  • 12.1.3 Johnson＆Johnson Daratumumab Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Johnson＆Johnson News

...

13 Research Findings and Conclusion

According to this study, over the next five years the Daratumumab market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Daratumumab business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Daratumumab market by product type, application, key manufacturers and key regions and countries.

This study considers the Daratumumab value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
100mg Injection
400mg Injection
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Multiple Myeloma
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Mantle Cell Lymphoma
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Johnson＆Johnson
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Daratumumab consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Daratumumab market by identifying its various subsegments.
Focuses on the key global Daratumumab manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Daratumumab with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Daratumumab submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.